These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Suppression of abdominal aortic aneurysm formation by AR-R17779, an agonist for the α7 nicotinic acetylcholine receptor. Watanabe A; Ichiki T; Kojima H; Takahara Y; Hurt-Camejo E; Michaëlsson E; Sankoda C; Ikeda J; Inoue E; Tokunou T; Kitamoto S; Sunagawa K Atherosclerosis; 2016 Jan; 244():113-20. PubMed ID: 26613536 [TBL] [Abstract][Full Text] [Related]
51. [The role of estrogen in the formation and development of abdominal aortic aneurysm: experiment with rats]. Wu XF; Zhang J; Xin SJ; Duan ZQ; Zhang G Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(7):471-4. PubMed ID: 17459227 [TBL] [Abstract][Full Text] [Related]
52. Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall. Kajimoto K; Miyauchi K; Kasai T; Shimada K; Kojima Y; Shimada A; Niinami H; Amano A; Daida H Atherosclerosis; 2009 Oct; 206(2):505-11. PubMed ID: 19406402 [TBL] [Abstract][Full Text] [Related]
56. Adventitial adipogenic degeneration is an unidentified contributor to aortic wall weakening in the abdominal aortic aneurysm. Doderer SA; Gäbel G; Kokje VBC; Northoff BH; Holdt LM; Hamming JF; Lindeman JHN J Vasc Surg; 2018 Jun; 67(6):1891-1900.e4. PubMed ID: 28912007 [TBL] [Abstract][Full Text] [Related]
57. Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction. Chew DK; Conte MS; Khalil RA J Vasc Surg; 2004 Nov; 40(5):1001-10. PubMed ID: 15557917 [TBL] [Abstract][Full Text] [Related]
58. [Effects of inflammatory infiltration on the formation of abdominal aortic aneurysm]. Zhang J; Wang X; Wang B; Xin S; Zhang Q; Duan Z Zhonghua Wai Ke Za Zhi; 1999 Mar; 37(3):177-9, 8. PubMed ID: 11829815 [TBL] [Abstract][Full Text] [Related]
59. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial. Thompson RW; Baxter BT Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728 [TBL] [Abstract][Full Text] [Related]
60. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Carrell TW; Burnand KG; Wells GM; Clements JM; Smith A Circulation; 2002 Jan; 105(4):477-82. PubMed ID: 11815431 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]